Sinopharm Group
(OTC) SHTDY
Sinopharm Group Financials at a Glance
Market Cap
$3.55B
Revenue (TTM)
$1.17T
Net Income (TTM)
$15.46B
EPS (TTM)
$1.51
P/E Ratio
8.74
Dividend
$0.47
Beta (Volatility)
0.35 (Low)
Dividend
$0.47
Beta (Volatility)
0.35 (Low)
Price
$13.22
Volume
77,958
Open
$13.40
Price
$13.22
Volume
77,958
Open
$13.40
Previous Close
$13.22
Daily Range
$13.17 - $13.46
52-Week Range
$10.72 - $14.87
Dividend
$0.47
Beta (Volatility)
0.35 (Low)
Price
$13.22
Volume
77,958
Open
$13.40
Previous Close
$13.22
Daily Range
$13.17 - $13.46
52-Week Range
$10.72 - $14.87
SHTDY News
SHTDY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sinopharm Group
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
108,217
Website
ir.sinopharmgroup.com.cnHeadquarters
Shanghai, 200023, CN
SHTDY Financials
Key Financial Metrics (TTM)
Gross Margin
7%
Operating Margin
3%
Net Income Margin
1%
Return on Equity
9%
Return on Capital
11%
Return on Assets
2%
Earnings Yield
11.44%
Dividend Yield
0.04%
Payout Ratio
71.41%
Stock Overview
Market Cap
$3.55B
Shares Outstanding
268.36M
Volume
77.96K
Short Interest
0.00%
Avg. Volume
50.44K
Financials (TTM)
Gross Profit
$44.26B
Operating Income
$16.19B
EBITDA
$20.17B
Operating Cash Flow
$11.55B
Capital Expenditure
$1.97B
Free Cash Flow
$9.58B
Cash & ST Invst.
$54.31B
Total Debt
$76.39B
Sinopharm Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$286.04B
-5.0%
Gross Profit
$20.78B
-10.7%
Gross Margin
7.26%
N/A
Market Cap
$3.55B
N/A
Market Cap/Employee
$32.78K
N/A
Employees
108,217
N/A
Net Income
$3.46B
-15.8%
EBITDA
$9.93B
-8.9%
Quarterly Fundamentals
Net Cash
$46.14B
+23.7%
Accounts Receivable
$244.13B
+1.1%
Inventory
$65.52B
-2.1%
Long Term Debt
$7.38B
-60.2%
Short Term Debt
$85.91B
+12.6%
Return on Assets
1.62%
N/A
Return on Invested Capital
10.76%
N/A
Free Cash Flow
$34.78B
+21.0%
Operating Cash Flow
$34.11B
+21.3%